Wall Street analysts forecast that Albemarle Corporation (NYSE:ALB) will announce earnings per share of $1.18 for the current quarter, Zacks reports. Five analysts have made estimates for Albemarle Corporation’s earnings, with the highest EPS estimate coming in at $1.27 and the lowest estimate coming in at $1.08. Albemarle Corporation reported earnings of $0.78 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 51.3%. The firm is scheduled to issue its next earnings results on Monday, February 26th.

On average, analysts expect that Albemarle Corporation will report full-year earnings of $4.42 per share for the current financial year, with EPS estimates ranging from $4.34 to $4.52. For the next fiscal year, analysts forecast that the firm will report earnings of $5.11 per share, with EPS estimates ranging from $4.74 to $5.40. Zacks Investment Research’s EPS averages are a mean average based on a survey of research firms that cover Albemarle Corporation.

Albemarle Corporation (NYSE:ALB) last released its quarterly earnings results on Wednesday, November 8th. The specialty chemicals company reported $1.08 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.07 by $0.01. Albemarle Corporation had a net margin of 30.07% and a return on equity of 11.61%. The business had revenue of $755.00 million for the quarter, compared to analysts’ expectations of $732.19 million. During the same period in the prior year, the firm earned $0.91 earnings per share. Albemarle Corporation’s revenue was up 15.4% compared to the same quarter last year.

Several analysts have recently commented on ALB shares. BidaskClub cut shares of Albemarle Corporation from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, July 25th. Loop Capital started coverage on shares of Albemarle Corporation in a research note on Thursday, September 28th. They set a “buy” rating and a $150.00 price target on the stock. Robert W. Baird reissued an “outperform” rating and set a $135.00 price target (up from $125.00) on shares of Albemarle Corporation in a research note on Tuesday, July 18th. They noted that the move was a valuation call. Royal Bank of Canada reissued a “buy” rating and set a $149.00 price target on shares of Albemarle Corporation in a research note on Wednesday, October 18th. Finally, KeyCorp reissued a “buy” rating and set a $125.00 price target on shares of Albemarle Corporation in a research note on Sunday, September 3rd. Eight analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $128.15.

COPYRIGHT VIOLATION NOTICE: “Albemarle Corporation (ALB) Expected to Post Earnings of $1.18 Per Share” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this piece can be read at https://www.watchlistnews.com/albemarle-corporation-alb-expected-to-post-earnings-of-1-18-per-share/1696639.html.

Albemarle Corporation (NYSE:ALB) traded down $0.22 on Friday, hitting $140.62. 1,056,300 shares of the stock traded hands, compared to its average volume of 1,173,828. Albemarle Corporation has a twelve month low of $76.32 and a twelve month high of $144.99. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.11 and a quick ratio of 1.67. The company has a market capitalization of $15,562.20, a PE ratio of 34.86, a P/E/G ratio of 2.16 and a beta of 1.72.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, January 2nd. Stockholders of record on Friday, December 15th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Thursday, December 14th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.91%. Albemarle Corporation’s dividend payout ratio is 16.56%.

In other news, EVP Matthew Juneau sold 5,397 shares of Albemarle Corporation stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $115.77, for a total transaction of $624,810.69. Following the transaction, the executive vice president now directly owns 360 shares of the company’s stock, valued at $41,677.20. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Karen G. Narwold sold 11,500 shares of Albemarle Corporation stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $115.95, for a total transaction of $1,333,425.00. Following the transaction, the executive vice president now directly owns 36,620 shares in the company, valued at $4,246,089. The disclosure for this sale can be found here. Company insiders own 0.74% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Carroll Financial Associates Inc. increased its position in Albemarle Corporation by 0.3% during the 2nd quarter. Carroll Financial Associates Inc. now owns 982 shares of the specialty chemicals company’s stock worth $103,000 after purchasing an additional 3 shares in the last quarter. Benjamin F. Edwards & Company Inc. lifted its position in Albemarle Corporation by 0.3% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 1,458 shares of the specialty chemicals company’s stock worth $154,000 after buying an additional 4 shares during the last quarter. Scotia Capital Inc. lifted its position in Albemarle Corporation by 0.5% in the second quarter. Scotia Capital Inc. now owns 2,022 shares of the specialty chemicals company’s stock worth $213,000 after buying an additional 10 shares during the last quarter. Alps Advisors Inc. lifted its position in Albemarle Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 4,606 shares of the specialty chemicals company’s stock worth $486,000 after buying an additional 12 shares during the last quarter. Finally, Northwestern Mutual Wealth Management Co. lifted its position in Albemarle Corporation by 2.1% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 968 shares of the specialty chemicals company’s stock worth $102,000 after buying an additional 20 shares during the last quarter. 83.82% of the stock is currently owned by institutional investors.

About Albemarle Corporation

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Get a free copy of the Zacks research report on Albemarle Corporation (ALB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Albemarle Corporation (NYSE:ALB)

Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.